Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials.
about
Human albumin solution for patients with cirrhosis and acute on chronic liver failure: Beyond simple volume expansionAlbumin reduces paracentesis-induced circulatory dysfunction and reduces death and renal impairment among patients with cirrhosis and infection: a systematic review and meta-analysisNephroprotective Potential of Human Albumin Infusion: A Narrative ReviewProtecting the Kidney in Liver Transplant Candidates: Practice-Based Recommendations From the American Society of Transplantation Liver and Intestine Community of Practice.Effects of paracentesis on hemodynamic parameters and respiratory function in critically ill patientsRole of human albumin in the management of complications of liver cirrhosis.Renal impairment in cirrhosis unrelated to hepatorenal syndromeAlbumin treatment regimen for type 1 hepatorenal syndrome: a dose-response meta-analysis.Large-volume paracentesis with indwelling peritoneal catheter and albumin infusion: a community hospital study.AISF-SIMTI position paper: the appropriate use of albumin in patients with liver cirrhosis.ATTIRE: Albumin To prevenT Infection in chronic liveR failurE: study protocol for a single-arm feasibility trial.The combination of octreotide and midodrine is not superior to albumin in preventing recurrence of ascites after large-volume paracentesis.Cross-Sectional Guidelines for Therapy with Blood Components and Plasma Derivatives: Chapter 5 Human Albumin - RevisedClinical use of albumin.Hypoalbuminemia.Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications.Kidney injury in cirrhosis: pathophysiological and therapeutic aspects of hepatorenal syndromes.Acute kidney injury and hepatorenal syndrome in cirrhosis.Paracentesis-induced circulatory dysfunction: a primer for the interventional radiologist.Managing complications in cirrhotic patientsHyponatremia in Patients with Cirrhosis of the Liver.Key Controversies in Colloid and Crystalloid Fluid Utilization.Albumin in chronic liver disease: structure, functions and therapeutic implications.Effects of alfapump™ system on kidney and circulatory function in patients with cirrhosis and refractory ascites.Insufficient evidence of benefit regarding mortality due to albumin substitution in HCC-free cirrhotic patients undergoing large volume paracentesis.Hepatorenal syndrome in cirrhosis: diagnostic, pathophysiological, and therapeutic aspects.Treatment for cirrhotic ascites.Reduced Albumin Dosing During Large-Volume Paracentesis Is Not Associated with Adverse Clinical Outcomes.Renal dysfunction in cirrhosis: acute kidney injury and the hepatorenal syndrome.Role of albumin in cirrhosis: from a hospitalist's perspective.NT-proBNP Changes in Patients with Ascites during Large Volume Paracentesis.Management of ascites and hepatorenal syndrome.Hepatobiliary quiz (answers)-13 (2015).Automated low flow pump system for the treatment of refractory ascites: a single-center experience.Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study.What we know about paracentesis induced circulatory dysfunction?Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III).Prevention of the Paracentesis-Induced Circulatory Dysfunction (PICD) in Cirrhosis: Is the SPA Treatment Worthwhile?A dedicated paracentesis clinic decreases healthcare utilization for serial paracenteses in decompensated cirrhosis.Current management of refractory ascites in patients with cirrhosis.
P2860
Q26765249-188B25F0-889D-4102-A46C-ECF33C257058Q27009006-2F682ADA-9ECB-49D7-8D42-65441FC743FEQ27015842-931E407E-6923-4815-8270-14FD7FDE9F68Q30251763-659F7D22-20C1-4220-8820-3D816BFE365DQ31148915-C1D639B1-3ACC-41CA-8D6B-CF5CECA7A31EQ35574320-8CA85402-9C8B-4209-B92E-5F30F10BBD9EQ35742662-CF0B56F7-0D9B-42AB-961B-54821FBEE3DAQ35852815-0CBFFBE3-AE1D-44BF-8D23-62907FE26797Q36179627-43E7A340-6DBE-4577-ABF6-76C5F258099FQ36515680-79CAA101-24CD-4892-9481-F070883674C9Q36527179-8BE9E8D3-AD6C-4C4C-8475-D40BB391730DQ36917870-813BD165-A9D5-4572-917D-0981DDF0F422Q37045780-BF63E8CD-CD93-4F91-9545-DFA339CE0DE1Q37370312-6334281B-820F-49C0-AD13-486F95C929B2Q38052843-9AAF5617-CBD0-43BF-8D88-F90BB1C7C10DQ38083035-840230BE-C0DD-46B3-BA16-256138BB4586Q38199770-2BA2D02D-628F-467C-BB66-EF9BB2D220B5Q38243669-0D09DC94-8E6B-4A1A-BBCC-61DDBC70B904Q38245219-B1BAA4F9-CD3D-4B99-BBB7-5A3B50CDD7D1Q38344890-2A559E8E-A06A-4193-A2E9-53699A4B7322Q38559606-A77DB04F-13D0-4C45-8879-F6EE6325305EQ38592705-F967AF79-384D-4F01-94E2-A167FBC27459Q38595462-2B636E0F-6D8B-49A5-9228-EE8E0DAF415EQ38743020-3D0E289F-C90C-4D14-ACB7-C7E7A4D7FCB4Q38826548-06F84E42-4916-4C13-87A1-718DB4DB726BQ38850006-2FD7A5FF-AC53-40AE-A69C-4B15DF46181EQ38882366-7ADC8FC8-FDCA-4905-AD8E-8572B6F9FDBAQ39034682-FAA19547-8CE2-4B8E-BFB4-D8D8ABF4DF47Q39323851-4EB144A3-66FF-4C5B-BD5B-257973D8CD32Q39387113-44F378EF-3128-48E6-9668-CC8D38B8F63FQ39660987-36F9F67A-90AF-4BC6-98C5-F17741797720Q40081708-F43B3134-227A-4693-82FB-1A138ED57C94Q40112074-5A9A119E-62A3-45A8-ABEB-A99A3134832EQ40322777-29BBCA05-A6E1-419C-B2AF-E400F568063CQ40816326-2D3DAAA2-5270-49B5-B98A-BD02B8BB4EB8Q43089477-555DBCA7-DD5C-4FEB-91C6-A2D99C284E97Q45394131-E57EA7EA-19A6-4D26-8506-AD9120FE3AFDQ46670015-4F7C8DAE-A722-4CFB-8C76-13FB8CDEA952Q47393940-FD7334CD-E2AF-46F3-B44C-02F3FF0E1D36Q47767771-2FA7FACF-5B67-4A78-AC67-101A5A9002B3
P2860
Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials.
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Albumin infusion in patients u ...... analysis of randomized trials.
@ast
Albumin infusion in patients u ...... analysis of randomized trials.
@en
Albumin infusion in patients u ...... analysis of randomized trials.
@nl
type
label
Albumin infusion in patients u ...... analysis of randomized trials.
@ast
Albumin infusion in patients u ...... analysis of randomized trials.
@en
Albumin infusion in patients u ...... analysis of randomized trials.
@nl
prefLabel
Albumin infusion in patients u ...... analysis of randomized trials.
@ast
Albumin infusion in patients u ...... analysis of randomized trials.
@en
Albumin infusion in patients u ...... analysis of randomized trials.
@nl
P2093
P2860
P356
P1433
P1476
Albumin infusion in patients u ...... analysis of randomized trials.
@en
P2093
Mahlon M Wilkes
Mauro Bernardi
Paolo Caraceni
Roberta J Navickis
P2860
P304
P356
10.1002/HEP.24786
P407
P577
2012-04-01T00:00:00Z